377 related articles for article (PubMed ID: 2663325)
21. Retinoids and phototherapy for psoriasis.
Monfrecola G; Baldo A
J Rheumatol Suppl; 2009 Aug; 83():71-2. PubMed ID: 19661548
[TBL] [Abstract][Full Text] [Related]
22. Modifications of PUVA.
Momtaz-T K; Fitzpatrick TB
Dermatol Clin; 1995 Oct; 13(4):867-73. PubMed ID: 8785890
[TBL] [Abstract][Full Text] [Related]
23. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
24. New roles for systemic retinoids.
Lebwohl M; Kathryn M
J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775
[TBL] [Abstract][Full Text] [Related]
25. [Psoriasis].
Pinto GM; Gonçalo MM; Resende C; Pereira A
Acta Med Port; 2001; 14(2):219-45. PubMed ID: 11475988
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy to treat moderate to severe psoriasis.
Lebwohl M; Menter A; Koo J; Feldman SR
J Am Acad Dermatol; 2004 Mar; 50(3):416-30. PubMed ID: 14988684
[TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
28. Adverse events from systemic therapies for psoriasis are common in clinical practice.
Pearce DJ; Higgins KB; Stealey KH; Balkrishnan R; Crane MM; Camacho F; Fleischer AB; Feldman SR
J Dermatolog Treat; 2006; 17(5):288-93. PubMed ID: 17092859
[TBL] [Abstract][Full Text] [Related]
29. Treatments for chronic palmoplantar pustular psoriasis.
Marsland AM; Griffiths CE
Skin Therapy Lett; 2001 Nov; 6(12):3-5. PubMed ID: 11753536
[TBL] [Abstract][Full Text] [Related]
30. Acitretin for the treatment of psoriasis: an assessment of national trends.
Ghasri P; Yentzer BA; Dabade TS; Feldman SR
J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids].
Orfanos CE; Pullmann H; Runne U; Kurka M; Strunk V; Künzig M; Dierlich E
Hautarzt; 1979 Mar; 30(3):124-33. PubMed ID: 374312
[TBL] [Abstract][Full Text] [Related]
32. Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
Umezawa Y; Mabuch T; Ozawa A
Pediatr Dermatol; 2012; 29(2):206-8. PubMed ID: 22409471
[TBL] [Abstract][Full Text] [Related]
33. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
34. [New aspects of the treatment of psoriasis].
Klemeyer-Smith A; Thune PO; Bjørneboe GE
Tidsskr Nor Laegeforen; 1990 May; 110(14):1817-9. PubMed ID: 2363144
[TBL] [Abstract][Full Text] [Related]
35. Treatment of psoriasis.
Bryant BG
Am J Hosp Pharm; 1980 Jun; 37(6):814-20. PubMed ID: 6994496
[TBL] [Abstract][Full Text] [Related]
36. A clinician's paradigm in the treatment of psoriasis.
Lebwohl M
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
[TBL] [Abstract][Full Text] [Related]
37. [Dithranol and combined treatment procedures: pro and con].
Mahrle G; Schulze HJ; Steigleder GK
Hautarzt; 1985 Jan; 36(1):34-9. PubMed ID: 3972577
[TBL] [Abstract][Full Text] [Related]
38. Acitretin. A review of its pharmacology and therapeutic use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 1377120
[TBL] [Abstract][Full Text] [Related]
39. Acitretin and etretinate. How and when they should be used.
Geiger JM; Saurat JH
Dermatol Clin; 1993 Jan; 11(1):117-29. PubMed ID: 8435906
[TBL] [Abstract][Full Text] [Related]
40. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Naldi L; Griffiths CE
Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
